Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
2.780
+0.200 (7.75%)
At close: Apr 25, 2025, 4:00 PM
2.780
0.00 (0.00%)
After-hours: Apr 25, 2025, 4:43 PM EDT

Orchestra BioMed Holdings Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-61.02-49.12-33.61-23.01-21.36
Depreciation & Amortization
0.310.290.220.180.14
Other Amortization
0.030.110.160.22-
Asset Writedown & Restructuring Costs
1.05----
Loss (Gain) From Sale of Investments
-1.43-3.8-1.630.292.93
Stock-Based Compensation
10.627.633.410.30.22
Other Operating Activities
0.672.082.6-0.030.07
Change in Accounts Receivable
0.02-00.030.05-0.08
Change in Inventory
-0.030.13-0.210-0.03
Change in Accounts Payable
2.970.153.351.08-2.61
Change in Unearned Revenue
-2.01-2.11-2.861.48-5.17
Change in Other Net Operating Assets
-1.72-1.47-0.760.03-0.31
Operating Cash Flow
-50.56-46.13-29.29-19.43-26.18
Capital Expenditures
-0.29-0.08-0.59-0.27-0.54
Cash Acquisitions
-0.6----
Investment in Securities
13.9810.77-63.5313.527.69
Other Investing Activities
----0.21-0.19
Investing Cash Flow
13.0910.69-64.1213.0226.97
Long-Term Debt Issued
15-10-10
Long-Term Debt Repaid
--10.85-6.45-4-
Net Debt Issued (Repaid)
15-10.853.55-410
Issuance of Common Stock
15.280.250.20.01-
Repurchase of Common Stock
-0.55----
Other Financing Activities
-0.5556.81-10.33--
Financing Cash Flow
29.1746.22103.26-3.9910
Net Cash Flow
-8.310.789.85-10.4110.78
Free Cash Flow
-50.85-46.21-29.88-19.7-26.72
Free Cash Flow Margin
-1927.48%-1674.09%-845.74%--468.56%
Free Cash Flow Per Share
-1.38-1.39-1.99-9.33-13.27
Cash Interest Paid
0.11.121.370.39-
Levered Free Cash Flow
-25.45-33.04-10.06-13.86-
Unlevered Free Cash Flow
-25.3-32.28-10.22-13.5-
Change in Net Working Capital
-4.267.92-7.150.08-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q